We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Protein Structural Changes Modulate Cell Adhesion

By Biotechdaily staff writers
Posted on 30 Jan 2004
Researchers have used x-ray crystallography techniques to elucidate structural changes that occur when the membrane protein vinculin binds to other proteins such as talin and actin.

Vinculin is a 117 kDa protein localized to focal adhesions. More...
The globular head region of vinculin (Vh) contains the binding sites for talin and alpha-actinin, whereas its rod-like tail domain (Vt) contains the binding sites for F-actin and paxillin. The crystal structure of Vt features a bundle of five amphipathic helices and a C-terminal arm, which emerges as a hydrophobic hairpin surrounded by a collar of basic residues. Vinculin is a conserved component and an essential regulator of both cell (cadherin-mediated) and cell-matrix (integrin–talin-mediated focal adhesions) junctions, and it anchors these adhesion complexes to the actin cytoskeleton by binding to talin in integrin complexes or to alpha-actinin in cadherin junctions.

Talin is a 270 kDa actin-binding protein that localizes to focal adhesions. Two talin molecules form a homodimer with an antiparallel orientation. Proteolysis with thrombin divides talin into an N-terminal head domain and a C-terminal rod domain. The C-terminal rod domain binds to the focal adhesion protein F-actin and to vinculin.

Investigators at St. Jude Children's Research Hospital (Memphis, TN, USA) wrote in the January 8, 2004, issue of Nature that talin binding induced marked conformational changes in Vh, creating a novel helical bundle structure, and this alteration actively displaced Vt from Vh. These results, as well as the ability of alpha-actinin to also bind to Vh and displace Vt from pre-existing Vh-Vt complexes, supported a model whereby Vh functioned as a domain that underwent marked structural changes that allowed vinculin to direct cytoskeletal assembly in focal adhesions and adherens junctions.

"Vinculin is a critical protein that performs different roles in the body,” explained senior author Dr. Philippe R.J. Bois, professor of genetics at St. Jude Children's Research Hospital. "It is a master conductor of much of the cell's life, changing its shape to conduct the cell's business according to the cell's immediate needs.”




Related Links:
St. Jude Children's Research Hospital

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.